Lv5
960 积分 2024-03-01 加入
Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function
6个月前
已完结
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
10个月前
已完结
Abstract CT063: First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies (NCT04886622)
11个月前
已关闭
Quantitative determination of betamethasone sodium phosphate and betamethasone dipropionate in human plasma by UPLC-MS/MS and a bioequivalence study
1年前
已完结
皖公网安备34019202002308
